abs72.txt	the	national	cancer	institute-led	multidisciplinary	comparative	brain	tumorconsortium	(cbtc)	convened	a	glioma	pathology	board		comprising	both	veterinarianand	physician	neuropathologists	and	conducted	comprehensive	review	of	193cases	canine	immediate	goal	was	to	improve	existing	gliomaclassification	methods	through	creation	histologic	atlas	features	thusyielding	greater	harmonization	phenotypic	characterization	long-term	goalwas	support	future	incorporation	clinical	outcomes	genomic	data	intoproposed	simplified	diagnostic	schema	so	as	further	bridge	worlds	ofveterinary	neuropathology	strengthen	validity	dog	anaturally	occurring	translationally	relevant	animal	model	human	allcases	were	morphologically	reclassified	according	new	devised	by	theentire	yielding	majority	opinion	diagnosis	astrocytoma	(43	22	3%)	19	which	low-grade	24	high-grade	oligodendroglioma	(134	69	4%)	35	99	sixteen	cases	(8	could	notbe	classified	or	based	on	morphology	alone	andwere	designated	undefined	gliomas	classification	schemeproposed	herein	provides	tractable	means	for	addition	molecular	also	serves	highlight	similarities	differences	betweenhuman
